Serositis and lymphopenia are common features of systemic lupus erythematosus following SARS‐CoV‐2 infection: A case report and literature review

DOI Web Site 被引用文献1件
  • Yoshiyuki Kioi
    Department of Respiratory Medicine and Clinical Immunology Suita Municipal Hospital Osaka Japan
  • Hideki Yorifuji
    Department of Respiratory Medicine and Clinical Immunology Suita Municipal Hospital Osaka Japan
  • Yuichi Higami
    Department of Respiratory Medicine and Clinical Immunology Suita Municipal Hospital Osaka Japan
  • Yoshinori Katada
    Department of Respiratory Medicine and Clinical Immunology Suita Municipal Hospital Osaka Japan

説明

<jats:title>Abstract</jats:title><jats:p>The coronavirus disease 2019 (COVID‐19) caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) can affect a number of human systems, including the respiratory, cardiovascular, neurological, gastrointestinal, and musculoskeletal systems. These symptoms persist long after the acute infection has healed and is called “long COVID”. Interestingly, there have been a series of reports that SARS‐CoV‐2 infections trigger the development of various autoimmune diseases such as systemic lupus erythematosus (SLE), inflammatory arthritis, myositis, vasculitis. Here, we report a novel case of SLE characterized by persistent pleural effusion and lymphopenia following SARS‐CoV‐2 infection. This is the first case in the Western Pacific region to our knowledge. Furthermore, we reviewed 10 similar cases including our case. By looking at the characteristics of each case, we found that serositis and lymphopenia are common features of SLE following SARS‐CoV‐2 infection. Our finding suggests that patients with prolonged pleural effusion and/or lymphopenia after COVID‐19 should be checked for autoantibodies.</jats:p>

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ